The anticancer drug B.N. Fuzailova – “MR-anti-protein-blocker”. The experience of testing it in the “IMEDIS-TEST” system

The anticancer drug B.N. Fuzailova – “MR-anti-protein-blocker”. The experience of testing it in the “IMEDIS-TEST” system

AUTHORS : Fuzailov B.N. | Shraibman M.M.

RELEVANT UNIVERSITIES : Moscow, Russia; Herzliya, Israel
YEAR : 2002 | Category : Research

Until now, the mechanism of the onset of a cancerous tumor has not been disclosed. All researchers cite various factors (physical, chemical, biological, genetic, polyetiological, and other theories) as the main causes of cancer. The following has been proven to date. Cancer is a consequence of profound disorders of plastic processes in the body; it never arises from perfectly healthy tissues.

With the development of cancer, the ban on cell division is lifted, as a result of which uncontrolled division and unrestrained growth occurs. At the same time, the cancer cell switches to the ancient path of energy production – anaerobic glycolysis. Cancer occurs as a result of a sharp weakening of the immune, neuro-endocrine systems, changes in acidbase and ionic equilibrium. One of the leading factors in carcinogenesis is the purity of the genetic line.

مطالب دیگر

Next Post
Miasmatic approach to diagnostics and therapy in the “IMEDIS-TEST” system
Previous Post
The tactics of treatment of patients with severe headaches are unknown etiology
برای نوشتن دیدگاه باید وارد بشوید.
فهرست